+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Erosive Esophagitis Drug"

Erosive Esophagitis - Pipeline Insight, 2024 - Product Thumbnail Image

Erosive Esophagitis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
From
Erosive Esophagitis - Epidemiology Forecast - 2032 - Product Thumbnail Image

Erosive Esophagitis - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
  • 4 Results (Page 1 of 1)
Loading Indicator

Erosive Esophagitis (EE) is a type of Gastrointestinal (GI) disorder that is caused by the inflammation of the esophagus due to acid reflux. EE is a common disorder, and is often treated with medications such as proton pump inhibitors (PPIs) and histamine-2 receptor antagonists (H2RAs). These medications are used to reduce the amount of acid produced in the stomach, and to reduce the symptoms of EE. The EE drug market is a subset of the larger GI drug market, and is composed of a variety of medications used to treat EE. These medications are available in both prescription and over-the-counter forms, and are used to reduce the symptoms of EE and to prevent further damage to the esophagus. The EE drug market is highly competitive, with many companies offering a variety of medications to treat EE. Some of the major companies in the EE drug market include AstraZeneca, Pfizer, GlaxoSmithKline, Merck, and Novartis. Show Less Read more